Literature DB >> 26729197

Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.

Xue-Bin Zhang1, Lei Song2, Hong-Juan Wen3, Xiao-Xue Bai4, Zhen-Juan Li1, Lian-Jun Ma5.   

Abstract

To verify the hypothesis that upregulation of microRNA-31 (miR-31) targeting integrin α5 (ITGA5) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway in human SGC7901 gastric cancer (GC) cells. The miRTarBase was used to predict whether ITGA5 is the target gene of miR-31, which was further confirmed by luciferase reporter gene assay. The SGC7901 GC cells were divided into five groups including the blank, miR-31 mimic, miR-31 mimic control, miR-31 inhibitor, and miR-31 inhibitor control groups. Reverse transcriptase-polymerase chain reaction (RT-PCR), western blotting, cell scratch test, and transwell assays were respectively performed in our study. TGA5 was found as the target gene of miR-31. The RT-PCR detection revealed that, compared with the blank group, ITGA5 messenger RNA (mRNA) expression decreased in the miR-31 mimic group, but increased in the miR-31 inhibitor group. The western blotting examination suggested that the expressions of ITGA5, PI3K, and AKT proteins reduced in the miR-31 mimic group, but enhanced in the miR-31 inhibitor group when compared to the blank group, respectively. The cell scratch and transwell assays indicated that the miR-31 expressions were negatively associated with GC cell migration and invasion. Besides, RT-PCR combined with western blotting demonstrated that the miR-31 expressions were higher in the normal tissues than those in the GC tissues, while the ITGA5 mRNA and protein showed lower expression in the normal tissues than they did in the GC tissues. Our study concluded that upregulation of miR-31 targeting ITGA5 may suppress tumor cell invasion and metastasis by indirectly regulating PI3K/AKT signaling pathway in human SGC7901 GC cells.

Entities:  

Keywords:  Cell invasion; Cell migration; Gastric cancer; Integrin α5; MicroRNA-31; Phosphoinositide 3-kinase (PI3K); Protein kinase B (AKT)

Mesh:

Substances:

Year:  2016        PMID: 26729197     DOI: 10.1007/s13277-015-4511-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Authors:  Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Journal:  Lancet       Date:  2010-08-19       Impact factor: 79.321

2.  World Medical Association publishes the Revised Declaration of Helsinki.

Authors:  P Nischal M
Journal:  Natl Med J India       Date:  2014 Jan-Feb       Impact factor: 0.537

Review 3.  Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis.

Authors:  Francesco Montagnani; Gina Turrisi; Claudio Marinozzi; Camillo Aliberti; Giammaria Fiorentini
Journal:  Gastric Cancer       Date:  2011-02-23       Impact factor: 7.370

Review 4.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

5.  miR-31 is a broad regulator of β1-integrin expression and function in cancer cells.

Authors:  Katarzyna Augoff; Mitali Das; Katarzyna Bialkowska; Brian McCue; Edward F Plow; Khalid Sossey-Alaoui
Journal:  Mol Cancer Res       Date:  2011-08-29       Impact factor: 5.852

6.  Macronutrient intake and stomach cancer.

Authors:  Jinfu Hu; Carlo La Vecchia; Eva Negri; Margaret de Groh; Howard Morrison; Les Mery
Journal:  Cancer Causes Control       Date:  2015-03-20       Impact factor: 2.506

7.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

8.  Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer.

Authors:  Jiaming Liu; Jin Huang; Yazhou He; Jinnan Liu; Banghua Liao; Ga Liao
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  13 in total

1.  MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.

Authors:  Guiqi Wang; Jingfeng Gu; Yingchao Gao
Journal:  Tumour Biol       Date:  2016-08-04

2.  MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.

Authors:  Alireza Korourian; Raheleh Roudi; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-24

3.  Chloroform fraction of Serratulae chinensis S. Moore suppresses proliferation and induces apoptosis via the phosphatidylinositide 3-kinase/Akt pathway in human gastric cancer cells.

Authors:  Qiaoyan Cai; Jing Lin; Ling Zhang; Shan Lin; Jun Peng
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

4.  Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection.

Authors:  Matthias Preusse; Klaus Schughart; Frank Pessler
Journal:  Front Immunol       Date:  2017-03-21       Impact factor: 7.561

5.  miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5.

Authors:  Linsen Feng; Jianhua Ma; Haiming Ji; Yichun Liu; Weixing Hu
Journal:  Biosci Rep       Date:  2017-06-21       Impact factor: 3.840

6.  p38 and JNK pathways control E-selectin-dependent extravasation of colon cancer cells by modulating miR-31 transcription.

Authors:  Liang Zhong; Bryan Simoneau; Jacques Huot; Martin J Simard
Journal:  Oncotarget       Date:  2017-01-03

7.  Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.

Authors:  Sabine Heublein; Markus Albertsmeier; David Pfeifer; Lisa Loehrs; Alexandr V Bazhin; Thomas Kirchner; Jens Werner; Jens Neumann; Martin Kurt Angele
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

8.  Down-regulation of circPVRL3 promotes the proliferation and migration of gastric cancer cells.

Authors:  Han-Dong Sun; Zhi-Peng Xu; Zhi-Qiang Sun; Bin Zhu; Qian Wang; Jian Zhou; Hui Jin; Andi Zhao; Wei-Wei Tang; Xiu-Feng Cao
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

9.  MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.

Authors:  Run-Fen Cheng; Jian Wang; Jing-Yi Zhang; Lin Sun; Yan-Rui Zhao; Zhi-Qiang Qiu; Bao-Cun Sun; Yan Sun
Journal:  Chin J Cancer       Date:  2016-07-02

10.  Resistant starch prevents tumorigenesis of dimethylhydrazine-induced colon tumors via regulation of an ER stress-mediated mitochondrial apoptosis pathway.

Authors:  Qiuyu Wang; Peng Wang; Zhigang Xiao
Journal:  Int J Mol Med       Date:  2018-01-25       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.